Galera Therapeutics (NASDAQ:GRTX) Coverage Initiated by Analysts at Credit Suisse Group
-
Summary:
Credit Suisse Group assumed coverage on shares of Galera Therapeutics (NASDAQ:GRTX) in a report issued on Monday, Benzinga reports. The firm issued a neutral rating and a $14.00 price target on the stock.
Other equities research analysts also recently issued research reports about the company. Bank of America started coverage on Galera Therapeutics in a report on Monday. They set a buy rating and a $15.00 price target on the stock. Citigroup started coverage on Galera Therapeutics in a report on Monday. They set a buy rating and a $20.00 price target on the stock.
Shares of NASDAQ GRTX opened at $12.07 on Monday. Galera Therapeutics has a 1-year low of $11.50 and a 1-year high of $14.88.
In other Galera Therapeutics news, major shareholder Enterprise Associates 14 New acquired 416,66 ...
Read Full News: https://rivertonroll.com/news/2019/12/03/galera-therapeutics-nasdaqgrtx-coverage-initiated-by-analysts-at-credit-suisse-group.html
